GHB

DRUG2 trials

Sponsors

Erich Seifritz, Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Conditions

HIVMajor Depressive DisorderPharmacokinetic Interactions

Phase 1

Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat

CompletedNCT04322214

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaHIV, Pharmacokinetic Interactions

Start: 2020-01-30End: 2020-04-30Updated: 2020-07-22

Phase 2

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

CompletedNCT04082806

Erich SeifritzMajor Depressive Disorder

Start: 2020-08-06End: 2022-04-06Updated: 2022-05-12

Related Papers

REPURPOSING OF GAMMA-HYDROXYBUTYRATE IN DEPRESSION: A RANDOMIZED PLACEBO-CONTROLLED PROOF-OF-CONCEPT CLINICAL TRIAL

The International Journal of Neuropsychopharmacology2025-02-01

Absence of drug–drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat

Journal of Antimicrobial Chemotherapy2021-09-096 citations